LP-118
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LP-118, covering 2025-12-26 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) [Phase 1, Phase 2]